{"id":"https://openalex.org/W2415052159","doi":null,"title":"Potential use of aldose reductase inhibitors to prevent diabetic complications.","display_name":"Potential use of aldose reductase inhibitors to prevent diabetic complications.","alternate_titles":[],"publication_year":1990,"publication_date":"1990-06-01","ids":{"openalex":"https://openalex.org/W2415052159","mag":"2415052159","pmid":"https://pubmed.ncbi.nlm.nih.gov/2114249"},"language":"en","primary_location":{"id":"pmid:2114249","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2114249","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacy","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2415052159"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057144682","display_name":"Golden J. Zenon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44461941","display_name":"University of Houston","ror":"https://ror.org/048sx0r50","country_code":"US","type":"education","lineage":["https://openalex.org/I44461941"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G J Zenon","raw_affiliation_strings":["College of Pharmacy, University of Houston, TX 77030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmacy, University of Houston, TX 77030","institution_ids":["https://openalex.org/I44461941"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109844712","display_name":"Cyril V. Abobo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C V Abobo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027830604","display_name":"Barry L. Carter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B L Carter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5057841692","display_name":"Douglas Wilmot Ball","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D W Ball","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5002,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.57087938,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"9","issue":"6","first_page":"446","last_page":"457"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12533","display_name":"Aldose Reductase and Taurine","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12533","display_name":"Aldose Reductase and Taurine","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11142","display_name":"Advanced Glycation End Products research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aldose-reductase-inhibitors","display_name":"aldose reductase inhibitors","score":1.0},{"id":"https://openalex.org/keywords/diabetes-complications","display_name":"diabetes complications","score":0.9990000128746033},{"id":"https://openalex.org/keywords/polyol-pathway","display_name":"polyol pathway","score":0.8659999966621399},{"id":"https://openalex.org/keywords/sorbitol-accumulation","display_name":"sorbitol accumulation","score":0.968999981880188},{"id":"https://openalex.org/keywords/diabetic-cataract","display_name":"diabetic cataract","score":0.8510000109672546},{"id":"https://openalex.org/keywords/diabetic-neuropathy","display_name":"diabetic neuropathy","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hexokinase","display_name":"hexokinase","score":0.7110000252723694},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.9259999990463257},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8339999914169312},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7919999957084656},{"id":"https://openalex.org/keywords/spirohydantoin","display_name":"spirohydantoin","score":0.7480000257492065},{"id":"https://openalex.org/keywords/flavonoids","display_name":"flavonoids","score":0.8619999885559082},{"id":"https://openalex.org/keywords/carboxylic-acid-derivatives","display_name":"carboxylic acid derivatives","score":0.953000009059906}],"concepts":[{"id":"https://openalex.org/C2776439734","wikidata":"https://www.wikidata.org/wiki/Q414213","display_name":"Aldose reductase","level":3,"score":0.9896602034568787},{"id":"https://openalex.org/C136502266","wikidata":"https://www.wikidata.org/wiki/Q7226667","display_name":"Polyol pathway","level":4,"score":0.928362250328064},{"id":"https://openalex.org/C2776779347","wikidata":"https://www.wikidata.org/wiki/Q245280","display_name":"Sorbitol","level":2,"score":0.7963104248046875},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7790274620056152},{"id":"https://openalex.org/C2777374081","wikidata":"https://www.wikidata.org/wiki/Q4713968","display_name":"Aldose reductase inhibitor","level":4,"score":0.6699930429458618},{"id":"https://openalex.org/C2910800646","wikidata":"https://www.wikidata.org/wiki/Q414213","display_name":"Aldehyde Reductase","level":4,"score":0.6677361130714417},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5502172708511353},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5483381152153015},{"id":"https://openalex.org/C2776614240","wikidata":"https://www.wikidata.org/wiki/Q1259458","display_name":"Sorbinil","level":5,"score":0.5202963948249817},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.49472758173942566},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.374931275844574},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37086111307144165},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3345779776573181},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1462082862854004}],"mesh":[{"descriptor_ui":"D000449","descriptor_name":"Aldehyde Reductase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003920","descriptor_name":"Diabetes Mellitus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013401","descriptor_name":"Sugar Alcohol Dehydrogenases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D048909","descriptor_name":"Diabetes Complications","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:2114249","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2114249","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacy","raw_type":"Journal Article"},{"id":"mag:2415052159","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2114249","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2011343734","https://openalex.org/W1638882029","https://openalex.org/W1844604724","https://openalex.org/W4414072519","https://openalex.org/W2002709542","https://openalex.org/W2043521084","https://openalex.org/W3166385901","https://openalex.org/W2037504301","https://openalex.org/W999611063","https://openalex.org/W2156829110"],"abstract_inverted_index":{"Reviewed":[0],"are":[1,29,108],"(1)":[2],"the":[3,13,41,56,61,68,93,149,173,199,208],"biochemical":[4],"basis":[5],"and":[6,11,20,50,121,136,202],"pathophysiology":[7],"of":[8,23,33,45,70,76,85,111,127,139,151,167,205,210],"diabetic":[9,39,105,182,211],"complications":[10],"(2)":[12],"structure-activity":[14],"relationships,":[15],"pharmacology,":[16],"pharmacokinetics,":[17],"clinical":[18],"trials,":[19],"adverse":[21,165,203],"effects":[22,166,204],"aldose":[24,54,77,134,152],"reductase":[25,78,135,153],"inhibitors":[26],"(ARIs).":[27],"ARIs":[28,52,107,142,168,189,206],"a":[30,109],"new":[31],"class":[32,110],"drugs":[34],"potentially":[35],"useful":[36],"in":[37,60,82,146,154,157,207],"preventing":[38],"complications,":[40,183],"most":[42],"widely":[43],"studied":[44],"which":[46,101],"have":[47],"been":[48,162],"cataracts":[49],"neuropathy.":[51],"inhibit":[53],"reductase,":[55],"first,":[57],"rate-limiting":[58],"enzyme":[59],"polyol":[62,174],"metabolic":[63],"pathway.":[64],"In":[65],"nonphysiological":[66],"hyperglycemia":[67],"activity":[69],"hexokinase":[71],"becomes":[72],"saturated":[73],"while":[74],"that":[75,115,186],"is":[79,195],"enhanced,":[80],"resulting":[81],"intracellular":[83],"accumulation":[84],"sorbitol.":[86],"Because":[87],"sorbitol":[88,140],"does":[89],"not":[90,161,177],"readily":[91],"penetrate":[92],"cell":[94],"membrane":[95],"it":[96],"can":[97],"persist":[98],"within":[99],"cells,":[100],"may":[102,176],"lead":[103],"to":[104,133,197],"complications.":[106,212],"structurally":[112],"dissimilar":[113],"compounds":[114],"include":[116,169],"carboxylic":[117],"acid":[118],"derivatives,":[119],"flavonoids,":[120],"spirohydantoins.":[122],"The":[123,164],"major":[124],"pharmacologic":[125],"action":[126],"an":[128],"ARI":[129],"involves":[130],"competitive":[131],"binding":[132],"consequent":[137],"blocking":[138],"production.":[141],"delay":[143],"cataract":[144,155],"formation":[145,156],"animals,":[147],"but":[148],"role":[150],"human":[158],"diabetics":[159],"has":[160],"established.":[163],"hypersensitivity":[170],"reactions.":[171],"Although":[172],"pathway":[175],"be":[178,191],"solely":[179],"responsible":[180],"for":[181],"studies":[184],"suggest":[185],"therapy":[187],"with":[188],"could":[190],"beneficial.":[192],"Further":[193],"research":[194],"needed":[196],"determine":[198],"long-term":[200],"impact":[201],"treatment":[209]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2415052159","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
